000 | 00978 a2200277 4500 | ||
---|---|---|---|
005 | 20250515020824.0 | ||
264 | 0 | _c20061019 | |
008 | 200610s 0 0 eng d | ||
022 | _a1070-5295 | ||
024 | 7 |
_a10.1097/01.ccx.0000216582.87674.a4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWischmeyer, Paul E | |
245 | 0 | 0 |
_aThe glutamine story: where are we now? _h[electronic resource] |
260 |
_bCurrent opinion in critical care _cApr 2006 |
||
300 |
_a142-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aBurns _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCritical Care |
650 | 0 | 4 |
_aGlutamine _xmetabolism |
650 | 0 | 4 |
_aHSP70 Heat-Shock Proteins _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMeta-Analysis as Topic |
773 | 0 |
_tCurrent opinion in critical care _gvol. 12 _gno. 2 _gp. 142-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.ccx.0000216582.87674.a4 _zAvailable from publisher's website |
999 |
_c16152174 _d16152174 |